GEODE CAPITAL MANAGEMENT, LLC - DIPEXIUM PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of DIPEXIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$56,000
-18.8%
43,447
+0.5%
0.00%
Q4 2016$69,000
-88.9%
43,219
+0.4%
0.00%
Q3 2016$624,000
+90.2%
43,067
+29.8%
0.00%
Q2 2016$328,000
+4.1%
33,1700.0%0.00%
Q1 2016$315,000
-7.4%
33,170
+9.1%
0.00%
Q4 2015$340,000
-19.8%
30,411
+0.3%
0.00%
Q3 2015$424,000
+207.2%
30,335
+178.3%
0.00%
Q2 2015$138,000
-6.8%
10,9010.0%0.00%
Q1 2015$148,000
+19.4%
10,9010.0%0.00%
Q4 2014$124,000
+14.8%
10,9010.0%0.00%
Q3 2014$108,00010,9010.00%
Other shareholders
DIPEXIUM PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Lone Star Value Management LLC 229,841$2,574,0004.76%
KINGDON CAPITAL MANAGEMENT, L.L.C. 975,099$10,921,0000.53%
Timpani Capital Management LLC 95,647$1,071,0000.44%
Broadfin Capital, LLC 465,978$5,219,0000.32%
1492 Capital Management LLC 34,819$390,0000.28%
Tourbillon Capital Partners, L.P. 791,856$8,869,0000.20%
Opus Point Partners Management, LLC 25,000$280,0000.18%
683 Capital Management, LLC 70,000$784,0000.11%
ARDSLEY ADVISORY PARTNERS LP 50,000$560,0000.07%
BOOTHBAY FUND MANAGEMENT, LLC 14,198$159,0000.07%
View complete list of DIPEXIUM PHARMACEUTICALS INC shareholders